Novel Features of RASopathies: Liver Disease as an Emerging Phenotype
Alyssa L Rippert1,2, Alanna Strong1,3, Rebecca C Ahrens-Nicklas1,3
1Division of Human Genetics, Children's Hospital of Philadelphia, Philadelphia, Pennsylvania, USA.
RASopathies, genetic conditions from RAS/MAPK pathway variants, frequently involve liver issues. Neonatal hyperbilirubinemia and cholestasis are common, particularly in infants with BRAF variants, necessitating liver disease screening.
Area of Science:
- Genetics
- Pediatrics
- Hepatology
Background:
- RASopathies are genetic disorders caused by variants in RAS/MAPK pathway genes.
- Liver involvement is recognized but not systematically studied in RASopathies.
- Lack of data hinders clinical guidance and screening for liver disease in these patients.
Purpose of the Study:
- To systematically characterize the spectrum and frequency of liver involvement in individuals with RASopathies.
- To identify specific RASopathy genotypes associated with particular liver pathologies.
- To inform clinical management and screening protocols for liver disease in RASopathy patients.
Main Methods:
- Retrospective analysis of 192 patients with molecularly confirmed RASopathy.
- Data abstraction from medical records for liver-related clinical information.
- Statistical analysis to determine the prevalence and risk factors for liver involvement.
Main Results:
- 36.5% of patients exhibited liver involvement.
- Neonatal hyperbilirubinemia occurred in 33.3%, with 24% requiring phototherapy (OR 7.1).
- Cholestasis was more frequent in patients with BRAF variants (OR 6.2).
Conclusions:
- RASopathies are strongly associated with neonatal liver disease, including hyperbilirubinemia and cholestasis.
- Liver function evaluation is recommended for infants with RASopathies.
- Individuals with BRAF variants may require closer monitoring for cholestasis.
Related Concept Videos
Diseases of the Liver and Gallbladder
Cirrhosis is characterized by the scarring of hepatic lobules in the liver, which are replaced by fibrous tissue, affecting the liver's normal functioning. NAFLD, on the other hand, is caused by an excessive build-up of fat in the liver, not...
Gastroesophageal Reflux Disease II: Clinical Features and Management
Clinical Manifestations
GERD presents itself in a multitude of ways, with symptoms varying from person to person. The hallmark symptoms are...
Emerging Adulthood
Effect of Hepatic Disease on Pharmacokinetics: Pathophysiologic Assessment and Liver Function Test
Introduction Cardiac Emergencies
Applications of GIS: Disaster Management and Emergency Response


